Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 18Sarcoma 10Gynecologic 7CNS 7Lymphoid 5Other hematologic neoplasm 4Other solid neoplasm 3Myeloid 3Head & Neck 3Gastrointestinal 3Plasma cell 2Endocrine 2Dermatologic 2Thoracic 1Breast 1

Conditions

Melanoma 19Lymphoma, T-Cell, Cutaneous 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Lymphoma, Non-Hodgkin 16Lymphoma, Mantle-Cell 16Lymphoma, Large-Cell, Immunoblastic 16Lymphoma, Large B-Cell, Diffuse 16Lymphoma, Follicular 16Lymphoma, B-Cell, Marginal Zone 16Leukemia, Lymphocytic, Chronic, B-Cell 16Burkitt Lymphoma 16Lymphoma 15Hodgkin Disease 14Sezary Syndrome 13Mycosis Fungoides 13Leukemia 11Multiple Myeloma 10Leukemia, Myeloid, Acute 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Myeloproliferative Disorders 9Myelodysplastic Syndromes 9Lymphoma, Large-Cell, Anaplastic 9Neoplasms, Plasma Cell 7Leukemia, Myelomonocytic, Chronic 7Leukemia, Myeloid, Chronic-Phase 7Leukemia, Myeloid, Accelerated Phase 7Leukemia, Hairy Cell 7Dendritic Cell Sarcoma, Interdigitating 7Recurrence 6Primary Myelofibrosis 6

Interventions

aldesleukin 15pembrolizumab 11Cyclophosphamide 9fludarabine phosphate 7fludarabine 6Nivolumab 6Interleukin-2 6atezolizumab 5Radiotherapy 5Ipilimumab 4Interferon-alpha 4Drug Therapy 4Blood Specimen Collection 4Radiosurgery 3tremelimumab 2temsirolimus 2durvalumab 2cemiplimab 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Paclitaxel 2Metformin 2Interleukin-12 Subunit p35 2Genistein 2Gene Expression Profiling 2Flow Cytometry 2Filgrastim 2Cetuximab 2zanolimumab 1vivitrol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Kidney Neoplasms × Filgrastim × Dermatologic × Clear all
NCT00704938 2015-10-28

Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
3 enrolled 8 charts
DermatologicGenitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Melanoma

NCT00004135 2014-03-07

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer

University of Chicago

Phase 2 Completed
19 enrolled
DermatologicGenitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡